Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study
-
- STATUS
- Recruiting
-
- End date
- May 31, 2024
-
- participants needed
- 300
-
- sponsor
- Chinese PLA General Hospital
Summary
Combined F index, A index,ATT index and spleen stiffness to predict tumor recurrence in different liver settings after thermal ablation of HCC.
Description
Thermal ablation is one of the established method for HCC treatment. Postoperative recurrence of HCC is one of the major factors leading to poor prognosis of HCC patients. Most studies have shown that the risk factors of recurrence include tumor size, tumor number and intrahepatic spread, etc.
Besides, the carcinogenic effects of inflammatory activity and fibrosis in liver background caused by chronic hepatitis also be related to the recurrence. In the study, combi-elastography imaging technology , not only the F index which is related to liver fibrosis stage can be obtained, but also the A index which is related to inflammation activity can be measured, this may provide a more valuable method for tumor recurrence of early prediction.
Details
| Condition | HEPATOCELLULAR CARCINOMA, Recurrent Tumor, Recurrence Tumor, Tumor Recurrence, neoplasm recurrence, liver cell carcinoma, the Predictive Power of Combined Elastography for Tumor Recurrence in Different Liver Settings After Thermal Ablation of HCC |
|---|---|
| Clinical Study Identifier | NCT04640363 |
| Sponsor | Chinese PLA General Hospital |
| Last Modified on | 2 February 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer